Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Iagnosis
AddedFeb 15, 2024
UpdatedJun 18, 2026
Iagnosis

Iagnosis

Seed

Iagnosis: Leading provider of teledermatology solutions for healthcare systems and practices.

HQ
Pittsburgh, PA, US
Founded
2012
Overview
Compare
Fundraising
Employees

Iagnosis is a leading provider of teledermatology solutions, focusing on delivering advanced dermatology services through digital platforms. The company aims to enhance accessibility and efficiency in dermatological care for healthcare systems and practices. Their core mission is to integrate teledermatology into the health system value chain, ensuring high-quality patient care.

Iagnosis has made significant strides in the telehealth industry, offering innovative solutions that streamline dermatological consultations and treatments. Their impact is evident in the improved patient outcomes and increased access to specialized care.

Iagnosis - Similar Companies

FirstDerm logo

FirstDerm

firstderm.com

Piction Health logo

Piction Health

lumindx.com

Direct Dermatology logo

Direct Dermatology

directderm.com

iHealthScreen logo

iHealthScreen

ihealthscreen.org

Distinct Dermatology logo

Distinct Dermatology

Clinikally logo

Clinikally

clinikally.com

EZaccessMD logo

EZaccessMD

ezaccessmd.com

Accessible Diagnostics logo

Accessible Diagnostics

Diagnotes logo

Diagnotes

backlinehealth.com

Pathology Watch logo

Pathology Watch

pathologywatch.com

iDocsWeb logo

iDocsWeb

idocsweb.com

My NextDerma logo

My NextDerma

mynextderma.com

NoviMedicine logo

NoviMedicine

ClickMedix logo

ClickMedix

clickmedix.com

CurieDx logo

CurieDx

curiedx.com

Iagnosis - Quick Facts

Who are Iagnosis' competitors?

Companies similar to Iagnosis include FirstDerm, Piction Health, Direct Dermatology and iHealthScreen.

When was Iagnosis founded?

Iagnosis was founded in 2012.

Where is Iagnosis' headquarters located?

Iagnosis' headquarters is located in Pittsburgh, PA, US.

When was Iagnosis' last funding round?

Iagnosis' most recent funding round was for $2.1M (USD) in June 2017.

How much has Iagnosis raised to-date?

As of Jun 15, 2017, Iagnosis has raised a total of $17M (USD).

How many employees does Iagnosis have?

Iagnosis has 30 employees as of Feb 5, 2024.

Iagnosis - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Healthcare
  • Teledermatology
Tags
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541512Computer Systems Design Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7379Computer Related Services, Not Elsewhere Classified
ISIC
  • 6202Computer consultancy and computer facilities management activities